Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Viral Hepatitis I: Introduction

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

Hepatitis

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

Graves' Disease I: Introduction

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...

Autoimmune Disorders

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...

Gastritis-II: Pathophysiology

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...

Cirrhosis I: Introduction

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The ImproveCareNow registry: Prediction of 2-year nonremission in pediatric ulcerative colitis.

Journal of pediatric gastroenterology and nutrition·2026

Same author

Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease: A Nationwide Survey of Anti-TNF Therapy Practices, Attitudes, and Barriers.

Crohn's & colitis 360·2025

Same author

The Pediatric Experience Collaborative: Paving the Way in Pediatric Experience.

Journal of patient experience·2025

Same author

Standardized biopsy protocols improve adherence to eosinophilic esophagitis and celiac disease endoscopic biopsy guidelines.

JPGN reports·2025

Same author

National perspectives of barriers by insurance and pharmacy benefit managers in pediatric inflammatory bowel disease.

JPGN reports·2025

Same author

Travel Time to Treating Center Is Associated With Diagnostic Delay in Pediatric Inflammatory Bowel Disease.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2024

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Autoimmune hepatitis: a review.

Talha Aziz Malik¹, Shehzad Saeed

¹Division of Gastroenterology and Hepatology, University of Alabama, Birmingham.

JPMA. the Journal of the Pakistan Medical Association

|June 10, 2010

Summary

Autoimmune Hepatitis (AIH) is an immune condition primarily affecting women, triggered by environmental factors in genetically susceptible individuals. Current treatments involve immunosuppression, with ongoing research into safer alternatives due to steroid side effects.

Area of Science:

Hepatology
Immunology
Internal Medicine

Background:

Autoimmune Hepatitis (AIH) is characterized by inflammation in the liver's periportal areas, elevated immunoglobulins, and autoantibodies.
AIH predominantly affects women and is believed to result from an environmental trigger activating a T-cell response against liver antigens in genetically susceptible individuals.

Purpose of the Study:

To review the diagnostic criteria and current treatment guidelines for Autoimmune Hepatitis.
To highlight the limitations of current therapies and the need for novel treatments.

Main Methods:

Diagnosis relies on excluding other liver diseases and utilizing the International Autoimmune Hepatitis Group (IAIHG) scoring system (2008).
Treatment follows American Association for the Study of Liver Diseases (AASLD) guidelines (2002), primarily using corticosteroids and azathioprine.

More Related Videos

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Related Experiment Videos

Last Updated: Jun 12, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Main Results:

Corticosteroids, a cornerstone of AIH treatment, are associated with significant complication risks.
Newer immunomodulators and biologics are under investigation for improved efficacy and safety profiles.

Conclusions:

Effective management of Autoimmune Hepatitis requires adherence to established diagnostic and treatment protocols.
Further research into alternative therapies is crucial to mitigate the risks associated with conventional immunosuppression and improve patient outcomes.